Jazz Pharmaceuticals plc — Director's Dealing 2018

Feb 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2018-02-26

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-26	Ordinary Shares	F	1445	$147.44	Disposed	30950	Direct
2018-02-27	Ordinary Shares	F	864	$143.8	Disposed	30086	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 73 ordinary shares acquired on November 30, 2017 under a Section 423 Employee Stock Purchase Plan.